Cystic fibrosis (CF) is thought to be rare in the black populations of Africa who have minimal white admixture. Only a few cases have been reported but have not been studied at the molecular level. We report the detection of CFTR mutations in three southern African black patients.
Abstract
Cystic fibrosis (CF) is thought to be rare in the black populations of Africa who have minimal white admixture. Only a few cases have been reported but have not been studied at the molecular level. We report the detection of CFTR mutations in three southern African black patients.
One was homozygous for the 3120 + 1G-*A mutation, while the other two were compound heterozygotes each with this mutation on one chromosome. The other mutations were G1249E and a previously unreported in frame 54 bp deletion within exon 17a involving nucleotides (3196del54). The 3120 + 1G->A mutation was first described in American black patients and has been shown to be a common mutation in this population (9-14% of CF chromosomes). It was also found in a black CF patient whose father, the 3120 + 1G-4A carrier, is from Cameroon.
These data suggest that it is an old mutation which accounts for many of the CFTR mutations in African blacks. ( This is the first report of CFTR mutations in black patients with no known white admixture. The chiefdoms of the parents are as follows: patient 1, both parents Venda; patient 2, mother Sotho, father Tswana; patient 3, mother Xhosa, father of unknown chiefdom. The clinical diagnosis of CF was made in these three cases by repeat positive sweat tests and symptoms compatible with and suggestive of CF. None had meconium ileus and all were pancreatic insufficient and had chronic lung infections. All had sputum cultures positive for Pseudomonas aeruginosa and two were positive for Staphylococcus aureus. By using PCR followed by denaturing gradient gel electrophoresis (DGGE) and sequencing of aberrant migrating or heteroduplex bands, the CFTR gene was scanned exon by exon. The methodology described by Fanen et ar and Claustres et at was used with minor modifications. Altered mobilities were observed for PCR products containing exons 16, 17a, and 20 from the three patients ( fig 1A) . Direct sequencing of the PCR products showed two known CFTR mutations (3120 + 1 G->A and G1249E) and a previously unreported mutation (3196del54).
The 3120 + 1G-A mutation in intron 16, a splice site mutation that affects the invariant G at position + 1 of the donor site (Macek et al, in press), was identified in four of the six CFTR genes. The remaining CFTR genes had the G1249E mutation, a missense mutation owing to a G to A transition at nucleotide 3878 in exon 2010 and the deletion mutation, 3196del54. The 54 bp deletion affects a region of exon 17a, starting at nucleotide 3196 and predicting the loss of 18 amino acid residues (from codon 1022 to codon 1039) in the 10th transmembrane domain (TM10) of the CFTR protein ( fig 1B) . XV  KM  D9  J44  6a  470  1898  2694  3601  3.11   1  Mother  3120  1  1  2  2  1  7  1  2  2  2  2  Father  3120  1  1  2  2  1  7  1  2  2  2  2  2  Mother  3120  1  1  2  2  1  7  1   2t   2  2  2  Father  G1249E  1  1  2  2  1  7  1   1  1  1  1  3  Mother   3120  1  1  1  7  1  2  2  2  2  Father  3196  1  1  7 
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